Contamination prompts voluntary injectables recall

Mylan N.V. has announced a voluntary recall of specific lots of injectable products for conditions including rheumatoid arthritis, severe psoriasis, lung cancer, breast cancer, ovarian cancer, and acute nonlymphocytic leukemia because foreign particles were observed during testing of retention...
Source: Skin and Allergy News - Category: Dermatology Tags: IMN News RHEUM News RHEUM Rheumatoid Arthritis SAN Clinical News SAN News SAN Psoriasis FPN News Source Type: news